Top-10 macro trade ideas (Q2 update)


This is an update and follow-up to our January publication; we cover our favourite macro trade ideas in rates/currency/credit/equities
Group Research07 Apr 2022
  • Rates: SGD and CNY rates outperformance to continue
  • Currencies: We are long USDCNY, USDTHB, and EURGBP
  • Credit: Maintaining positivity on Thai banks’ subordinated bonds
  • Equities: China/HK equities are too cheap to ignore
Photo credit: Unsplash Photo


Idea #1: SGD rates outperformance to last         

Idea #2: China’s divergences to be reflected in outperformance of CNY rates

Idea #3: Receive 5Y MYR IRS vs pay 5Y THB OIS on differing risk profiles

Idea #4: Long USD vs CNY on “dovish PBOC, hawkish Fed”

Idea #5: Take profit on long USD/JPY and shift to a long USD/THB strategy

Idea #6: Switching from a “short EUR, long SGD” strategy to a long EUR/GBP play

Idea #7: Maintaining positivity on Thai banks’ subordinated bonds

Idea #8: Wary of uneven impact from oil shocks on energy and basic materials

Idea #9 China/HK equities are too cheap to ignore

Idea #10: Stay long with the STI’s re-opening theme        


To read the full report, click here to Download the PDF.

Taimur Baig, Ph.D.

Chief Economist - Global
taimurbaig@dbs.com

 

Chang Wei Liang

FX & Credit Strategist, Global
weiliangchang@dbs.com

Nathan Chow 

Senior Economist and Strategist - China & Hong Kong 
nathanchow@dbs.com

Eugene Leow

Senior Rates Strategist - G3 & Asia
eugeneleow@dbs.com

Duncan Tan

Rates Strategist - Asia
duncantan@dbs.com

Philip Wee

Senior FX Strategist - G3 & Asia
philipwee@dbs.com

Dennis Lam Che Jung

Team Head, Equities Research
dennis_lam@dbs.com

Yeo Kee Yan

Specialist, Equities
keeyan@dbs.com


Subscribehereto receive our economics & macro strategy materials.
To unsubscribe, please clickhere.

The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). This report is intended for “Accredited Investors” and “Institutional Investors” (defined under the Financial Advisers Act and Securities and Futures Act of Singapore, and their subsidiary legislation), as well as “Professional Investors” (defined under the Securities and Futures Ordinance of Hong Kong) only. It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation.  Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies.  The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation.  The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.

This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.

DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E. 

DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability.  18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability.  13th Floor One Island East, 18 Westlands Road, Quarry Bay, Hong Kong SAR

Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply.  The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.